Medicaid prescription drug coverage: state efforts to control costs.
This paper provides a brief summary of the Medicaid prescription drug benefit. It explains the mechanisms being used by states to control their prescription drug spending within the Medicaid program. The paper also highlights some of the concerns that have been expressed with these mechanisms and the litigation that has been initiated in several states as a result of these efforts. It takes a closer look at three states with cost-containment strategies that have been the focus of increased scrutiny.
Dawn M
DM
Gencarelli
D003363:Cost Control; D017047:Cost Sharing; D019468:Disease Management; D016527:Drug Costs / Q000639:trends; D011307:Drug Prescriptions / Q000191:economics; D016568:Drugs, Generic / Q000191:economics / Q000627:therapeutic use; D005544:Forecasting; D005569:Formularies as Topic; D017754:Group Purchasing / Q000191:economics; D006291:Health Policy / Q000191:economics* / Q000331:legislation & jurisprudence / Q000639:trends; D006801:Humans; D007356:Insurance, Pharmaceutical Services / Q000191:economics* / Q000331:legislation & jurisprudence / Q000639:trends; D008329:Managed Care Programs / Q000191:economics / Q000331:legislation & jurisprudence / Q000639:trends; D008389:Marketing of Health Services / Q000191:economics / Q000331:legislation & jurisprudence; D008484:Medicaid / Q000191:economics* / Q000331:legislation & jurisprudence / Q000639:trends; D010605:Pharmacy Administration / Q000191:economics; D012051:Reimbursement Mechanisms / Q000191:economics / Q000331:legislation & jurisprudence / Q000639:trends; D013219:State Government; D014481:United States
D016568:Drugs, Generic